Propiedad y actividad de insiders de AN2 Therapeutics, Inc. (ANTX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.34 |
| Capitalización | $192M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-15 | Trenor Cameron C. III | A-Award | 233,333 | $1.3M |
| 2026-09-15 | Trenor Cameron C. III | A-Award | 116,667 | |
| 2026-09-09 | Readnour Robin Shane | S-Sale | 585 | $4K |
| 2026-09-09 | Readnour Robin Shane | S-Sale | 523 | $3K |
| 2026-09-03 | Readnour Robin Shane | S-Sale | 3,223 | $20K |
| 2026-09-08 | Readnour Robin Shane | S-Sale | 5,294 | $32K |
| 2026-09-03 | Readnour Robin Shane | S-Sale | 2,877 | $17K |
| 2026-09-08 | Readnour Robin Shane | S-Sale | 4,725 | $28K |
| 2026-09-01 | Williams Sarah Joanne | S-Sale | 272 | $2K |
| 2026-09-01 | FitzPatrick Margaret M | P-Purchase | 2,098 | $12K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.6M | $4.1M | $12.1M | $27.2M | $15.6M | $21.4M | $19.9M |
| Inversiones a Corto | 0 | 0 | $46.5M | $68.8M | $91.6M | $62.3M | $38.1M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $300000 | $900000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $5.7M | $4.2M | $60.1M | $98.6M | $110.5M | $86.3M | $59.9M |
| Inmovilizado Material | 0 | 0 | 0 | $53000 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $5.7M | $4.2M | $65.3M | $102.6M | $138.7M | $92.1M | $62.0M |
| Cuentas por Pagar | $51000 | $132000 | $1.1M | $2.1M | $2.7M | $3.3M | $3.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $159000 | $1.5M | $3.4M | $7.2M | $14.0M | $10.2M | $8.7M |
| Deuda a Largo | $728000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $887000 | $1.5M | $3.4M | $7.2M | $14.0M | $10.2M | $8.9M |
| Reservas | -$5.8M | -$20.3M | -$47.4M | -$89.7M | -$154.5M | -$205.8M | -$240.9M |
| Patrimonio Neto | $4.8M | $2.8M | $61.9M | $95.4M | $124.7M | $81.8M | $53.1M |
| Deuda Total | $728000 | 0 | 0 | $53000 | 0 | 0 | 0 |
| Deuda Neta | -$4.9M | -$4.1M | -$58.6M | -$96.0M | -$107.3M | -$83.6M | -$58.0M |
| Capital Circulante | $5.5M | $2.8M | $56.7M | $91.4M | $96.5M | $76.0M | $51.2M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 14.32 |
Rentabilidad
| Rentabilidad sobre capital | -53.52% |
| Rentabilidad sobre capital invertido | -51.01% |
| Rentabilidad sobre activos | -44.41% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: BOLD · IBIO · INTS · ITRM · NXTC · PLUR · PSTV
Explorar sector: Healthcare · Biotechnology
Más secciones de ANTX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones